Literature DB >> 11356973

Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity.

T Watanabe1, S Watanabe, H Ito, H Kida, Y Kawaoka.   

Abstract

Ion channel proteins are common constituents of cells and have even been identified in some viruses. For example, the M2 protein of influenza A virus has proton ion channel activity that is thought to play an important role in viral replication. Because direct support for this function is lacking, we attempted to generate viruses with defective M2 ion channel activity. Unexpectedly, mutants with apparent loss of M2 ion channel activity by an in vitro assay replicated as efficiently as the wild-type virus in cell culture. We also generated a chimeric mutant containing an M2 protein whose transmembrane domain was replaced with that from the hemagglutinin glycoprotein. This virus replicated reasonably well in cell culture but showed no growth in mice. Finally, a mutant lacking both the transmembrane and cytoplasmic domains of M2 protein grew poorly in cell culture and showed no growth in mice. Thus, influenza A virus can undergo multiple cycles of replication without the M2 transmembrane domain responsible for ion channel activity, although this activity promotes efficient viral replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356973      PMCID: PMC114278          DOI: 10.1128/JVI.75.12.5656-5662.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus.

Authors:  K Tobler; M L Kelly; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein.

Authors:  S L Zebedee; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Fusion mutants of the influenza virus hemagglutinin glycoprotein.

Authors:  R S Daniels; J C Downie; A J Hay; M Knossow; J J Skehel; M L Wang; D C Wiley
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

4.  Genetic applications of an inverse polymerase chain reaction.

Authors:  H Ochman; A S Gerber; D L Hartl
Journal:  Genetics       Date:  1988-11       Impact factor: 4.562

5.  Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.

Authors:  R B DuBridge; P Tang; H C Hsia; P M Leong; J H Miller; M P Calos
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

6.  Nucleoproteins of animal influenza viruses, in contrast to those of human strains, are not cleaved in infected cells.

Authors:  O Zhirnov; A G Bukrinskaya
Journal:  J Gen Virol       Date:  1984-06       Impact factor: 3.891

7.  Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?

Authors:  Y Kawaoka; C W Naeve; R G Webster
Journal:  Virology       Date:  1984-12       Impact factor: 3.616

8.  Amantadine-resistance as a genetic marker for influenza viruses.

Authors:  G Appleyard
Journal:  J Gen Virol       Date:  1977-08       Impact factor: 3.891

9.  A potassium channel protein encoded by chlorella virus PBCV-1.

Authors:  B Plugge; S Gazzarrini; M Nelson; R Cerana; J L Van Etten; C Derst; D DiFrancesco; A Moroni; G Thiel
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

10.  The molecular basis of the specific anti-influenza action of amantadine.

Authors:  A J Hay; A J Wolstenholme; J J Skehel; M H Smith
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  43 in total

1.  The NB protein of influenza B virus is not necessary for virus replication in vitro.

Authors:  Masato Hatta; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 2.  Influenza vaccines: present and future.

Authors:  Peter Palese; Adolfo García-Sastre
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 3.  Comparative NMR studies demonstrate profound differences between two viroporins: p7 of HCV and Vpu of HIV-1.

Authors:  Gabriel A Cook; Hua Zhang; Sang Ho Park; Yan Wang; Stanley J Opella
Journal:  Biochim Biophys Acta       Date:  2010-08-18

4.  A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice.

Authors:  Alec W Freyn; Jamile Ramos da Silva; Victoria C Rosado; Carly M Bliss; Matthew Pine; Barbara L Mui; Ying K Tam; Thomas D Madden; Luís Carlos de Souza Ferreira; Drew Weissman; Florian Krammer; Lynda Coughlan; Peter Palese; Norbert Pardi; Raffael Nachbagauer
Journal:  Mol Ther       Date:  2020-04-19       Impact factor: 11.454

5.  Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations.

Authors:  Yacine Abed; Nathalie Goyette; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells.

Authors:  Svetlana V Bourmakina; Adolfo García-Sastre
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 7.  Viroporins customize host cells for efficient viral propagation.

Authors:  Kristina M Giorda; Daniel N Hebert
Journal:  DNA Cell Biol       Date:  2013-08-14       Impact factor: 3.311

8.  Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus.

Authors:  Masaki Imai; Kazunori Kawasaki; Takato Odagiri
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Free-energy profiles for ions in the influenza M2-TMD channel.

Authors:  Morad Mustafa; Douglas J Henderson; David D Busath
Journal:  Proteins       Date:  2009-09

Review 10.  Influenza vaccines.

Authors:  A H Ellebedy; R J Webby
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.